- Advertisement -
- Advertisement -
- Advertisement -

Find a job

Subscribe for free

All things Pharma


Two new directors at GSK

 GSK has appointed two new Non-Executive Directors who will join the company’s board from 1st April 2011.

Judy Lewent and Stacey Cartwright will both become members of the GSK’s Audit and Risk Committee when they commence their roles.

Sir Christopher Gent, Chairman of GSK (pictured), said he was “delighted” to welcome the two, who will use their experience to “bring a fresh, external perspective to the board”.

Ms Lewent has a number of years experience within the pharmaceutical industry and is the former Executive Vice President and Chief Financial Officer of Merck. Ms Cartwright is currently the Executive Vice President, Chief Financial Officer of Burberry Group.

- Advertisement -


- Advertisement -



Sign up to receive our digital newsletter, for all the essential headlines, Jobs of the Week and thought-provoking features.

Claim my free subscription